Inogen Inc $ 38.84 0.29 (0.75%)
Volume:
178,113
Avg Vol (1m):
379,783
Market Cap $:
856.33 Mil
Enterprise Value $:
658.96 Mil
P/E (TTM):
61.65
P/B:
2.46
Financial Strength | 8/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 18.98 | ||
| Equity-to-Asset | 0.76 | ||
| Debt-to-Equity | 0.03 | ||
| Debt-to-EBITDA | 0.39 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 6.35 | ||
| Beneish M-Score | -2.08 | ||
| WACC vs ROIC | |||
Profitability Rank | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 3.54 | ||
| Net Margin % | 3.9 | ||
| ROE % | 4.16 | ||
| ROA % | 3.28 | ||
| ROC (Joel Greenblatt) % | 20.04 | ||
| 3-Year Revenue Growth Rate | 19.2 | ||
| 3-Year EBITDA Growth Rate | -4.2 | ||
| 3-Year EPS without NRI Growth Rate | -1 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 61.65 | ||
| PE Ratio without NRI | 61.65 | ||
| Price-to-Owner-Earnings | 123.3 | ||
| PB Ratio | 2.46 | ||
| PS Ratio | 2.39 | ||
| Price-to-Free-Cash-Flow | 23.99 | ||
| Price-to-Operating-Cash-Flow | 20.08 | ||
| EV-to-EBIT | 51.69 | ||
| EV-to-EBITDA | 23.32 | ||
| EV-to-Revenue | 1.83 | ||
| PEG Ratio | 8.74 | ||
| Current Ratio | 5.43 | ||
| Quick Ratio | 4.75 | ||
| Days Inventory | 60.32 | ||
| Days Sales Outstanding | 40.93 | ||
| Days Payable | 35.16 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.9 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 3.56 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 1.17 | ||
| Price-to-Peter-Lynch-Fair-Value | 8.69 | ||
| Price-to-Graham-Number | 3.12 | ||
| Earnings Yield (Greenblatt) % | 1.91 | ||
| Forward Rate of Return (Yacktman) % | 11.14 |